Breast cancer heterogeneity and its implication in personalized precision therapy

被引:144
作者
Guo, Liantao [1 ]
Kong, Deguang [1 ]
Liu, Jianhua [1 ]
Zhan, Ling [1 ]
Luo, Lan [3 ]
Zheng, Weijie [1 ]
Zheng, Qingyuan [2 ]
Chen, Chuang [1 ]
Sun, Shengrong [1 ]
机构
[1] Wuhan Univ, Dept Breast & Thyroid Surg, Renmin Hosp, 238 Jiefang Rd, Wuhan 430060, Hubei, Peoples R China
[2] Wuhan Univ, Dept Urol, Renmin Hosp, 238 Jiefang Rd, Wuhan 430060, Hubei, Peoples R China
[3] Guizhou Med Univ, Dept Breast Surg, Affiliated Hosp, 28 Guiyi Rd, Guiyang 550001, Guizhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Breast cancer; Heterogeneity; Cell interaction; Cell competition; Precision therapy; TUMOR-ASSOCIATED MACROPHAGES; ANTIBODY-DRUG CONJUGATE; EPITHELIAL-MESENCHYMAL TRANSITION; CELL-CELL INTERACTIONS; SINGLE-CELL; PROGESTERONE-RECEPTOR; ESTROGEN-RECEPTOR; GENE-EXPRESSION; MOLECULAR CHARACTERIZATION; ANTITUMOR-ACTIVITY;
D O I
10.1186/s40164-022-00363-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer heterogeneity determines cancer progression, treatment effects, and prognosis. However, the precise mechanism for this heterogeneity remains unknown owing to its complexity. Here, we summarize the origins of breast cancer heterogeneity and its influence on disease progression, recurrence, and therapeutic resistance. We review the possible mechanisms of heterogeneity and the research methods used to analyze it. We also highlight the importance of cell interactions for the origins of breast cancer heterogeneity, which can be further categorized into cooperative and competitive interactions. Finally, we provide new insights into precise individual treatments based on heterogeneity.
引用
收藏
页数:27
相关论文
共 300 条
[1]   Luminal B Breast Cancer: Molecular Characterization, Clinical Management, and Future Perspectives [J].
Ades, Felipe ;
Zardavas, Dimitrios ;
Bozovic-Spasojevic, Ivana ;
Pugliano, Lina ;
Fumagalli, Debora ;
de Azambuja, Evandro ;
Viale, Giuseppe ;
Sotiriou, Christos ;
Piccart, Martine .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (25) :2794-+
[2]   Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials [J].
Albain, K. ;
Anderson, S. ;
Arriagada, R. ;
Barlow, W. ;
Bergh, J. ;
Bliss, J. ;
Buyse, M. ;
Cameron, D. ;
Carrasco, E. ;
Clarke, M. ;
Correa, C. ;
Coates, A. ;
Collins, R. ;
Costantino, J. ;
Cutter, D. ;
Cuzick, J. ;
Darby, S. ;
Davidson, N. ;
Davies, C. ;
Davies, K. ;
Delmestri, A. ;
Di Leo, A. ;
Dowsett, M. ;
Elphinstone, P. ;
Evans, V. ;
Ewertz, M. ;
Gelber, R. ;
Gettins, L. ;
Geyer, C. ;
Goldhirsch, A. ;
Godwin, J. ;
Gray, R. ;
Gregory, C. ;
Hayes, D. ;
Hill, C. ;
Ingle, J. ;
Jakesz, R. ;
James, S. ;
Kaufmann, M. ;
Kerr, A. ;
MacKinnon, E. ;
McGale, P. ;
McHugh, T. ;
Norton, L. ;
Ohashi, Y. ;
Paik, S. ;
Pan, H. C. ;
Perez, E. ;
Peto, R. ;
Piccart, M. .
LANCET, 2012, 379 (9814) :432-444
[3]   Review of Microwaves Techniques for Breast Cancer Detection [J].
Aldhaeebi, Maged A. ;
Alzoubi, Khawla ;
Almoneef, Thamer S. ;
Bamatraf, Saeed M. ;
Attia, Hussein ;
Ramahi, Omar M. .
SENSORS, 2020, 20 (08)
[4]   Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries [J].
Allemani, Claudia ;
Matsuda, Tomohiro ;
Di Carlo, Veronica ;
Harewood, Rhea ;
Matz, Melissa ;
Niksic, Maja ;
Bonaventure, Audrey ;
Valkov, Mikhail ;
Johnson, Christopher J. ;
Esteve, Jacques ;
Ogunbiyi, Olufemi J. ;
Azevedo e Silva, Gulnar ;
Chen, Wan-Qing ;
Eser, Sultan ;
Engholm, Gerda ;
Stiller, Charles A. ;
Monnereau, Alain ;
Woods, Ryan R. ;
Visser, Otto ;
Lim, Gek Hsiang ;
Aitken, Joanne ;
Weir, Hannah K. ;
Coleman, Michel P. .
LANCET, 2018, 391 (10125) :1023-1075
[5]   Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study [J].
Alva, Ajjai S. ;
Mangat, Pam K. ;
Garrett-Mayer, Elizabeth ;
Halabi, Susan ;
Hansra, Damien ;
Calfa, Carmen J. ;
Khalil, Maged F. ;
Ahn, Eugene R. ;
Cannon, Timothy L. ;
Crilley, Pamela ;
Fisher, Julie G. ;
Haslem, Derrick S. ;
Shrestha, Sagun ;
Antonelli, Kaitlyn R. ;
Butler, Nicole L. ;
Warren, Sasha L. ;
Rygiel, Andrew L. ;
Ranasinghe, Shamika ;
Bruinooge, Suanna S. ;
Schilsky, Richard L. .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (22) :2443-+
[6]   The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging [J].
Amin, Mahul B. ;
Greene, Frederick L. ;
Edge, Stephen B. ;
Compton, Carolyn C. ;
Gershenwald, Jeffrey E. ;
Brookland, Robert K. ;
Meyer, Laura ;
Gress, Donna M. ;
Byrd, David R. ;
Winchester, David P. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (02) :93-99
[7]   Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast Cancer [J].
Amir, Eitan ;
Miller, Naomi ;
Geddie, William ;
Freedman, Orit ;
Kassam, Farrah ;
Simmons, Christine ;
Oldfield, Maria ;
Dranitsaris, George ;
Tomlinson, George ;
Laupacis, Andreas ;
Tannock, Ian F. ;
Clemons, Mark .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (06) :587-592
[8]   Spatial deconvolution of HER2-positive breast cancer delineates tumor-associated cell type interactions [J].
Andersson, Alma ;
Larsson, Ludvig ;
Stenbeck, Linnea ;
Salmen, Fredrik ;
Ehinger, Anna ;
Wu, Sunny Z. ;
Al-Eryani, Ghamdan ;
Roden, Daniel ;
Swarbrick, Alex ;
Borg, Ake ;
Frisen, Jonas ;
Engblom, Camilla ;
Lundeberg, Joakim .
NATURE COMMUNICATIONS, 2021, 12 (01)
[9]   Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2enegative advanced breast cancer: final overall survival results from SOLAR-1 [J].
Andre, F. ;
Ciruelos, E. M. ;
Juric, D. ;
Loibl, S. ;
Campone, M. ;
Mayer, I. A. ;
Rubovszky, G. ;
Yamashita, T. ;
Kaufman, B. ;
Lu, Y-S ;
Inoue, K. ;
Papai, Z. ;
Takahashi, M. ;
Ghaznawi, F. ;
Mills, D. ;
Kaper, M. ;
Miller, M. ;
Conte, P. F. ;
Iwata, H. ;
Rugo, H. S. .
ANNALS OF ONCOLOGY, 2021, 32 (02) :208-217
[10]   Precision medicine for metastatic breast cancer-limitations and solutions [J].
Arnedos, Monica ;
Vicier, Cecile ;
Loi, Sherene ;
Lefebvre, Celine ;
Michiels, Stefan ;
Bonnefoi, Herve ;
Andre, Fabrice .
NATURE REVIEWS CLINICAL ONCOLOGY, 2015, 12 (12) :693-704